Corcept Therapeutics Incorporated announced the appointment of Monica Tellado as President, Emerging Markets. She will report to Joseph K. Belanoff, MD, Corcept’s Chief Executive Officer, and join the company’s Executive Team. Ms. Tellado’s prior role was at Heartflow, where she served as Chief Financial Officer. At Corcept, Ms. Tellado will serve as the global commercial lead for therapeutics in metabolism and neurology. She will also oversee pipeline and portfolio planning activities across the company’s other therapeutic areas.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on CORT:
- Corcept Therapeutics Announces Third Quarter Financial Results and Provides Corporate Update
- Corcept Appoints Monica Tellado as President, Emerging Markets
- CORT Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Corcept Therapeutics initiates MONARCH trial
- Corcept Initiates MONARCH – A Phase 2b Trial in Non-Alcoholic Steatohepatitis (NASH)